In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Practice Guideline Track on Myocardial Revascularization

Guidelines into Practice

Coronary Artery Disease (Chronic)
Cardiovascular Surgery
Acute Cardiac Care


Contributor:  Special thanks to Professor Dirk Sibbing

Based on the 2018 ESC/EACTS Guidelines in Myocardial Revascularisation.

Overview of the Guideline

Session Slides Webcast
2018 ESC/EACTS Guidelines on Myocardial Revascularization - Introduction.    
Diagnostic tools to guide myocardial revascularization.    
Myocardial revascularization in patients with stable coronary artery disease.    
Myocardial revascularization in patients with acute coronary syndromes.    
Technical aspects of CABG.    
Technical aspects of PCI.    
Antithrombotic therapy.    
2018 ESC/EACTS Guidelines on Myocardial Revascularization - Conclusion.    
What's new with PCI?    
What's new with CABG?    
Task Force Panel.    

 

Clinical Presentation

Topic Session Title Slides Webcast
coronary artery disease, acute coronary syndromes, acute cardiac care Optimal antithrombotic treatment in the first year post PCI for ACS    
coronary artery disease, acute coronary syndromes, acute cardiac care Optimal antithrombotic treatment beyond the first year post PCI for ACS    
interventional cardiology and cardiovascular surgery De-escalation of dual antiplatelet therapy intensity in acute coronary syndrome.    
coronary artery disease, acute coronary syndromes, acute cardiac care FFR, iFR and Pd/Pa: evaluation of coronary physiology before revascularisation    
interventional cardiology and cardiovascular surgery Non-culprit lesions in primary PCI - Which and when to treat    
interventional cardiology and cardiovascular surgery Revascularization decisions in cardiogenic shock    
interventional cardiology and cardiovascular surgery Surgical coronary revascularization - State of the art    
imaging My patient has chest pain: which imaging modality should I use? - Take Home Message.    
coronary artery disease, acute coronary syndromes, acute cardiac care Can too much of a good thing be dangerous? Current status of lesion preparation in coronary intervention.    
coronary artery disease, acute coronary syndromes, acute cardiac care Coronary devices: how to choose today and what we will be doing 10 years from now.    
coronary artery disease, acute coronary syndromes, acute cardiac care Dual vs triple therapy in atrial fibrillation post-PCI: how has the story evolved?    
arrhythmias and device therapy Comprehensive patient care: from OAC choice to post-PCI (and beyond).    
interventional cardiology and cardiovascular surgery Treatment of complex bifurcations - Take Home Message.    
coronary artery disease, acute coronary syndromes, acute cardiac care Bleeding complication while on DAPT after PCI.    
interventional cardiology and cardiovascular surgery Interventional strategies in LM, bifurcation and CTO treatment.    
interventional cardiology and cardiovascular surgery Update on intracoronary imaging and physiology guided PCI.    
interventional cardiology and cardiovascular surgery Revascularization of multivessel disease in STEMI - an algorithm for success.    
interventional cardiology and cardiovascular surgery Radial access is it! Here are the tips and tricks.    
coronary artery disease, acute coronary syndromes, acute cardiac care GLOBAL LEADERS TRIAL - A randomized comparison of 24 month ticagrelor and 1 month aspirin versus 12 month dual antiplatelet therapy followed by aspirin monotherapy    
interventional cardiology and cardiovascular surgery ART - Randomised comparison of bilateral versus single internal thoracic coronary artery bypass graft surgery: effects on mortality at ten years follow-up in the Arterial Revascularisation Trial (ART)